Olivia Friett discusses the future of pharmaceutical manufacturing with Britton Jimenez, SVP, sales and marketing, Codexis at CPHI Milan.
As the pharmaceutical industry responds to growing demand for complex therapeutics, manufacturers are reassessing how they design and scale processes. Addressing these challenges requires new manufacturing approaches that improve scalability, quality and strengthen supply chain resilience.
Following CPHI Milan 2026, Codexis shares the investment priorities and manufacturing strategies shaping the next generation of pharmaceutical production, including how advances in biocatalysis, RNA manufacturing and process engineering can support more sustainable commercial production.
